Masimo (NASDAQ:MASI) Issues FY24 Earnings Guidance

Masimo (NASDAQ:MASI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided EPS guidance of $3.95-$4.10 for the period, compared to the consensus EPS estimate of $3.88. The company issued revenue guidance of $2.075-$2.105 billion, compared to the consensus revenue estimate of $2.10 billion. Masimo also updated its Q4 2024 guidance to 1.350-1.500 EPS.

Analysts Set New Price Targets

A number of research analysts have recently issued reports on the stock. BTIG Research boosted their price target on shares of Masimo from $166.00 to $170.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. Needham & Company LLC restated a “hold” rating on shares of Masimo in a report on Wednesday. Wells Fargo & Company upped their price target on shares of Masimo from $160.00 to $171.00 and gave the company an “overweight” rating in a research report on Wednesday. Piper Sandler lifted their price objective on Masimo from $165.00 to $180.00 and gave the stock an “overweight” rating in a research report on Wednesday. Finally, Raymond James raised Masimo from a “market perform” rating to an “outperform” rating and set a $170.00 price objective on the stock in a research note on Wednesday. Three analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $152.57.

Masimo Stock Down 3.7 %

Shares of NASDAQ MASI traded down $6.28 during trading on Thursday, hitting $161.35. 952,749 shares of the company traded hands, compared to its average volume of 683,751. The firm has a market capitalization of $8.58 billion, a price-to-earnings ratio of 109.76 and a beta of 0.97. The business’s fifty day moving average is $132.63 and its 200 day moving average is $125.88. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.15 and a current ratio of 2.09. Masimo has a fifty-two week low of $75.36 and a fifty-two week high of $173.90.

Masimo (NASDAQ:MASI) last posted its quarterly earnings results on Tuesday, November 5th. The medical equipment provider reported $0.98 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.14. Masimo had a return on equity of 14.07% and a net margin of 3.94%. The business had revenue of $504.60 million for the quarter, compared to the consensus estimate of $502.87 million. During the same period in the prior year, the business earned $0.63 EPS. The firm’s revenue for the quarter was up 5.4% on a year-over-year basis. Equities research analysts predict that Masimo will post 3.88 earnings per share for the current fiscal year.

About Masimo

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of carboxyhemoglobin, methemoglobin, hemoglobin concentration, fractional arterial oxygen saturation, oxygen content, pleth variability index, rainbow pleth variability index, respiration rate from the pleth, and oxygen reserve index, as well as acoustic respiration monitoring, SedLine brain function monitoring, NomoLine capnography and gas monitoring, and regional oximetry.